Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review
July 2019
53
About the Report
About the Report
Guerbet SA (GBT)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Guerbet SA (Guerbet) is a manufacturer of contrast agents. The company provides a wide range of imaging products, solutions and services for Computed Tomography (CT)/Cath Lab examinations, magnetic resonance imaging (MRI) and interventional imaging. CT/Cath Lab contrast agents consist of iodinated active ingredients; and few examinations of the digestive tract use barium-based products. MRI imaging uses gadolinium complexes. Guerbet has presence in Europe, Asia, Oceania and North and South America. The company offers products directly through its sales structure, distributors and license-holders. Guerbet is headquartered in Villepinte, France.
Guerbet SA Key Recent Developments
Jun 25,2019: MLCTO 2019: Once again, Guerbet partners in the initiatives implemented for interventional cardiologists
May 06,2019: Guerbet shows its commitment to supporting professionals in the field of interventional imaging with its launch of a specialized website
Apr 18,2019: Guerbet: 1st quarter 2019 revenue
Mar 26,2019: Guerbet: 2018 annual results
Feb 14,2019: Guerbet announces 2018 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Guerbet SA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
ulrich GmbH & Co KG
Terumo BCT Inc
SuperSonic Imagine SA
Sirtex Medical Europe GmbH
Nemoto Kyorindo Co Ltd
Merit Medical Systems Inc
Medtron AG
GE Healthcare LLC
Bracco Imaging France SAS
Boston Scientific Corp
Bayer AG
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Guerbet SA-Key Facts
Guerbet SA-Key Employees
Guerbet SA-Key Employee Biographies
Guerbet SA-Major Products and Services
Guerbet SA-History
Guerbet SA-Company Statement
Guerbet SA-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Guerbet SA-Business Description
Business Segment: Diagnostic Imaging
Overview
Performance
Business Segment: Interventional Imaging
Overview
Performance
Business Segment: Others
Performance
Geographical Segment: European Markets
Performance
Geographical Segment: Other Markets
Performance
R&D Overview
Guerbet SA-Corporate Strategy
Guerbet SA-SWOT Analysis
SWOT Analysis-Overview
Guerbet SA-Strengths
Guerbet SA-Weaknesses
Guerbet SA-Opportunities
Guerbet SA-Threats
Guerbet SA-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Guerbet SA, Medical Equipment, Deals By Year, 2013 to YTD 2019
Guerbet SA, Medical Equipment, Deals By Type, 2013 to YTD 2019
Guerbet SA, Recent Deals Summary
Section 5-Company's Recent Developments
Jun 25, 2019: MLCTO 2019: Once again, Guerbet partners in the initiatives implemented for interventional cardiologists
May 06, 2019: Guerbet shows its commitment to supporting professionals in the field of interventional imaging with its launch of a specialized website
Apr 18, 2019: Guerbet: 1st quarter 2019 revenue
Mar 26, 2019: Guerbet: 2018 annual results
Feb 14, 2019: Guerbet announces 2018 financial results
Oct 25, 2018: GUERBET: Revenue at September 30, 2018
Jul 26, 2018: GUERBET : Revenue at June 30 2018
Jul 10, 2018: IBM Watson Health and Guerbet to use AI in medical imaging
Jul 09, 2018: Guerbet Names Richard Hines as Head of Sales for New North American Interventional Imaging Division
Jun 25, 2018: GUERBET : 2018 half-year results
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Guerbet SA, Performance Chart (2014-2018)
Guerbet SA, Ratio Charts
Guerbet SA, Medical Equipment, Deals By Year, 2013 to YTD 2019
Guerbet SA, Medical Equipment, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Guerbet SA, Key Facts
Guerbet SA, Key Employees
Guerbet SA, Key Employee Biographies
Guerbet SA, Major Products and Services
Guerbet SA, History
Guerbet SA, Other Locations
Guerbet SA, Subsidiaries
Guerbet SA, Key Competitors
Guerbet SA, Ratios based on current share price
Guerbet SA, Annual Ratios
Guerbet SA, Annual Ratios (Cont...1)
Guerbet SA, Annual Ratios (Cont...2)
Guerbet SA, Interim Ratios
Guerbet SA, Medical Equipment, Deals By Year, 2013 to YTD 2019
Guerbet SA, Medical Equipment, Deals By Type, 2013 to YTD 2019
Guerbet SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.